“…There are several, albeit nonspecific, magnetic resonance imaging biomarkers such as dilated PVS, white matter hyperintensity, cerebral microbleeds, and superficial siderosis that characterize SVD, AD, and CAA that are an expression of impaired clearance of proteins and fluids, focal ischemia, and deposition of amyloid-beta within the walls of capillaries and neurodegeneration (82,(86)(87)(88)(89). Neural tissue can become stiffer via several processes such as Wallerian degeneration, axonal atrophy, loss of oligodendroglial cells, microglial activation, neuroinflammation, and microvascular damage, resulting in a range of microstructural changes from increased tissue water content to progressive gliosis and loss of volume.…”